World Preeclampsia Day

Overview

Preeclampsia, also known as “toxaemia of pregnancy”, is a serious blood pressure disorder that can occur during pregnancy or shortly after childbirth. It is a leading cause of death worldwide for women, fetuses and newborns, as it is responsible for over 70 OOO maternal deaths and 500 000 fetal deaths every year and affects approximately 5% to 7% of all pregnancies1. Preeclampsia is characterized by elevated blood pressure and high protein levels in the urine. The condition may be associated with severe short and long-term effects for both mother and baby2.

Diagnosis and Symptoms

The first symptoms of preeclampsia usually become apparent mid-pregnancy, after the 24th week of pregnancy, and rarely before the 20th week. Although less common, the mother may develop preeclampsia for the first time in the weeks immediately after birth. Most pregnant women with the condition only experience mild symptoms and feel no discomfort at the beginning, but severe complications may develop without early diagnosis and clinical management. During the first trimester prenatal appointments, a healthcare professional checks the mother for high blood pressure1and protein in the urine2, which are some of the early signs of preeclampsia. These clinical findings in combination with some risk factors, like having an existing medical problem or family history of the condition, help the healthcare professional identify whether the expecting mother has an increased risk developing preeclampsia. The main sign of preeclampsia in the fetus is slow growth, as the condition prevents the fetus from being adequately nourished and supplied with oxygen due to the poor blood supply through the placenta to the baby2. If the condition is not identified from an early stage and progresses, the expecting mother may develop severe headaches or vision problems like sensations of flashing lights, light sensitivity, or blurry vision or spots. Additional symptoms include severe heartburn, nausea or vomiting, rapid and excessive weight gain, pain just below the ribs, sudden or severe swelling of the feet, ankles, face and hands (edema). It is crucial for every pregnant woman to be informed about these symptoms and get medical advice immediately if they notice any of them. Without prompt treatment, preeclampsia may lead to rare, yet life-threatening complications for the mother, including organ damage and death. Preeclampsia is also associated with high risk of the baby being born too small and with a low birth weight.

Causes and Risk Factors

Despite intensive research over the last decades, the exact cause of preeclampsia isn't fully understood; however, it is thought to be caused by the placenta not developing properly2. Many factors can increase the risk of developing preeclampsia, including having a pre-existing medical problem such as diabetes, kidney disease, high blood pressure or autoimmune conditions like lupus or antiphospholipid syndrome. Also, if a woman had preeclampsia in a previous pregnancy, there is approximately a 16% chance of developing the condition again in later pregnancies. Some factors cumulatively increase a woman’s chances of developing preeclampsia. These include being pregnant for the first time, if it has been at least 10 years since last pregnancy, family history of the condition (mother or sister), whether a woman is over 40, if a woman was obese at the start of her pregnancy with body mass index (BMI) of 35 or more, or if having a multiple pregnancy.

Newest studies for Diagnosis

Apart from the first trimester routine checks which are performed between the 11th and 14th week of pregnancy to estimate the risk for preeclampsia, newer studies show that determining the ratio of two placental proteins (sFlt-1/PlGF) with a blood test between the 20th and 34th week can predict the onset of preeclampsia about four weeks in advance4,5. Based on this information, if preeclampsia is suspected, the healthcare professional can schedule the frequency of prenatal appointments accordingly, for more careful monitoring and early diagnosis. Monitoring may include keeping track of the fetus’s movements by doing a daily kick count, measuring the blood pressure at home and scheduling weekly prenatal check visits to check the fetus growth.

Treatment

If preeclampsia is confirmed, frequent monitoring by a healthcare professional is essential. Preeclampsia can only be cured by delivering the baby and the placenta2. The aim of treatment is to prolong pregnancy and avoid a premature birth, as long as it is safe for both the mother and the baby. If needed, staying in the hospital until the baby can be delivered will be recommended for careful monitoring and early action. Although preeclampsia usually improves soon after the baby is born, complications can sometimes develop a few days later. If preeclampsia is severe, it may cause long-term health consequences for the mother and her baby. On average, 1 in 3 women with severe preeclampsiadevelops chronic high blood pressure years after their pregnancy, and frequently suffers from cardiovascular diseases (CVD) and blood clotting disorders1, 2. As babies may be born prematurely, they may experience breathing difficulties caused by undeveloped lungs2. To prevent this from happening, healthcare professionals may give injections of a corticosteroid medicine to the pregnant women to speed up the development of the fetus’ lungs, brain, and kidneys and surfactant production. In newborns with underdeveloped lungs and breathing difficulties, treatment ­­― surfactant replacement therapy, breathing support from a ventilator or other supportive cures ― should begin immediately. Most babies who show signs of a breathing disorder are quickly moved to a neonatal intensive care unit (NICU) to receive constant treatment.

Prevention

Presently, there is no single diagnostic test that can accurately predict if a woman will develop preeclampsia during pregnancy or right after childbirth. For this reason, raising awareness to prevent preeclampsia is the most powerful tool for the successful, early recognition and clinical management of the condition3. This involves identifying risk factors for preeclampsia, informing women of the signs and symptoms, and stressing the importance of contacting a healthcare professional as soon as possible. It is crucial for pregnant women to attend all their prenatal appointments, to monitor their blood pressure at every prenatal check or at home, and to be aware of specific warning signals such as headaches, impaired vision or rapid weight gain, fluid retention or restlessness. Maintaining a healthy eating lifestyle, staying physically active and avoiding stress are vitally important for the prevention and good management of preeclampsia.

NIPD Genetics clinical laboratories, which are part of GESY, offer several routine checks which may be performed before or during the pregnancy. NIPD Genetics clinical laboratories enable easy access, and the experienced personnel is trained to respond to every need. To learn more please visit www.nipdlabs.com.cy

The content is intended only for educational purposes and should not be perceived as medical advice.

Compiled using information from:

-European Foundation for the Care of Newborn Infants (EFCNI). [https://www.efcni.org/activities/campaigns/world-preeclampsia-day/]

-NHS, Pre-eclampsia. [https://www.nhs.uk/conditions/pre-eclampsia/]

-ACOG, Preeclampsia and Pregnancy. [https://www.acog.org/womens-health/infographics/preeclampsia-and-pregnancy]

-ACOG, Preeclampsia and High Blood Pressure During Pregnancy. [https://www.acog.org/womens-health/faqs/preeclampsia-and-high-blood-pressure-during-pregnancy]

-NHLBI, Respiratory Distress Syndrome. [https://www.nhlbi.nih.gov/health-topics/respiratory-distress-syndrome]

-NIHR, Placental growth factor testing can speed up diagnosis of pre-eclampsia. [https://evidence.nihr.ac.uk/alert/placental-growth-factor-testing-can-speed-up-diagnosis-of-pre-eclampsia/]

References:

  1. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar 29;124(7):1094-1112. doi: 10.1161/CIRCRESAHA.118.313276. Erratum in: Circ Res. 2020 Jan 3;126(1):e8. PMID: 30920918.
  2. Bokslag A, van Weissenbruch M, Mol BW, de Groot CJ. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum Dev. 2016 Nov;102:47-50. doi: 10.1016/j.earlhumdev.2016.09.007. Epub 2016 Sep 20. PMID: 27659865.
  3. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122-1131. doi: 10.1097/01.AOG.0000437382.03963.88. PMID: 24150027.
  4. European Foundation for the Care of Newborn Infants (EFCNI). [https://www.efcni.org/activities/campaigns/world-preeclampsia-day/]
  5. Chau, K., Hennessy, A. & Makris, A. Placental growth factor and pre-eclampsia. J Hum Hypertens 31, 782–786 (2017). https://doi.org/10.1038/jhh.2017.61


Share
View All Posts

NIPD Genetics - Privacy Policy

General Statement

This Privacy Policy applies only to www.nipd.com and its subdomains (hereafter collectively referred to as “Sites") that link to this policy. NIPD Genetics Sites are owned by NIPD Genetics Public Company Ltd and are operated by NIPD Genetics Public Company Ltd and on occasion by a third-party that is responsible for the technical maintenance of the Sites.

If, you do not agree with this Privacy Policy, please do not access or use any of NIPD Genetics Sites.

NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.

Personal data for purposes of this Privacy Policy, is any information by which you can be individually identified, including, but not limited to, your name, profession, address, e-mail address, and telephone number.

You may contact NIPD Genetics Public Company Ltd at
NIPD Genetics Public Company Ltd
Neas Engomis 31
Engomi, Nicosia
2409, Cyprus

NIPD Genetics Data Protection Officer can be reached at dpo@nipd.com

This Privacy Policy applies only to the Sites as defined above and which are operated by NIPD Genetics. The NIPD Genetics Privacy Policy seeks to inform the users of its Sites of the following:

NIPD Genetics will not use or share your information with anyone, except as described in this Privacy Policy. This Privacy Policy does not apply to any information we might collect by other digital and offline means and or from other digital and offline sources. The use of information collected through our Sites shall be limited to the purposes under this Privacy Policy and our Terms of Use to customers.

This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.

We use your data to provide and improve the Sites. By using the Sites, you agree to the collection and use of information in accordance with this policy. Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as in our Terms and Conditions, accessible from www.nipd.com

Type of personal information NIPD Genetics may collect through its Sites

Information Collection And Use

We collect several different types of information for various purposes to provide and improve our Sites and services to you.

Personal Data

While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:

If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.

Cookies and Usage Data

Usage Data

We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.

Tracking & Cookies Data

We use cookies and similar tracking technologies to track the activity on our Sites and hold certain information.

Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.

You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.

Examples of Cookies we use:

Session Cookies. We use Session Cookies to operate our Sites.

Preference Cookies. We use Preference Cookies to remember your preferences and various settings.

Security Cookies. We use Security Cookies for security purposes.

Visitor behavior cookies. To understand how visitors use and navigate the Sites

Keyword cookies. To understand how visitors discover the Sites.

Use of Data

www.nipd.com uses the collected data for various purposes:

Transfer of Data

Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.

If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.

Your consent to this Privacy Policy followed by your submission of such information represents your agreement to that transfer.

www.nipd.com will take all reasonable steps necessary to ensure that your data is treated securely and in accordance with this Privacy Policy and no transfer of your personal data will take place to an organization or a country unless there are adequate controls in place including the security of your data and other personal information.

Disclosure of Data

NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.

NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:

Security of Data

The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.

Service Providers

We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.

These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.

Analytics

We may use third-party Service Providers to monitor and analyze the use of our Sites.

Google Analytics

Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.

You can opt-out of having made your activity on the Service available to Google Analytics by installing the Google Analytics opt-out browser add-on. The add-on prevents the Google Analytics JavaScript (ga.js, analytics.js, and dc.js) from sharing information with Google Analytics about visits activity.

For more information on the privacy practices of Google, please visit the Google Privacy & Terms web page

Access to your personal data, correction, deletion, and Opting Out

You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer pdo@nipd.com

Links to Other Sites

Our Sites may contain links to other sites that are not operated by us. If you click on a third-party link, you will be directed to that third party's site. We strongly advise you to review the Privacy Policy of every site you visit.

We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.

Children's Privacy

Our Service does not address anyone under the age of 18 ("Children").

We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.

Changes to This Privacy Policy

We may update our Privacy Policy from time to time. We will notify you of any changes by posting the new Privacy Policy on this page.

We will let you know via email and/or a prominent notice on our Service, prior to the change becoming effective and update the "effective date" at the top of this Privacy Policy.

You are advised to review this Privacy Policy periodically for any changes. Changes to this Privacy Policy are effective when they are posted on this page.

Contact Us

If you have any questions about this Privacy Policy, please contact pdo@nipd.com

Ok got it!